Article
Non-erythropoietic erythropoietin derivatives protect from light-induced and genetic photoreceptor degeneration.
Human molecular genetics - 1 Jun 2011
Colella Pasqualina, Iodice Carolina, Di Vicino Umberto, Annunziata Ida, Surace Enrico M, Auricchio Alberto
Abstract excerpt
Given the high genetic heterogeneity of inherited retinal degenerations (IRDs), a wide applicable treatment would be desirable to halt/slow progressive photoreceptor (PR) cell loss in a mutation-independent manner. In addition to its erythropoietic activity, erythropoietin (EPO) presents neurotrophic characteristics. We have previously shown that adeno-associated viral (AAV) vector-mediated systemic EPO delivery...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
